Having trouble accessing articles? Reset your cache.

HHS report finds Part D rebates not keeping up with rising drug prices

An HHS Office of the Inspector General report shows Medicare Part D rebates are not keeping up with rising prices for brand drugs.

The report examined 1,510 brand name Part D drugs that received rebates each year from 2011 to 2015.

Read the full 407 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE